William C Fanslow from 404 197Th St, Seattle, WA 98166, age 63, Phone: 206-592-8402

Name / Title

Company / Classification

Phones & Addresses

William Fanslow

ENEWWORLDJOBS.COM LLC

view source

Location:

Greater Seattle Area

Industry:

Biotechnology

Use Of Cd40 Ligand, A Cytokine That Binds Cd40, To Stimulate Hybridoma Cells
view source
US Patent:

6391637, May 21, 2002
Filed:

Dec 19, 1996
Appl. No.:

08/770981
Inventors:

Richard J. Armitage - Bainbridge Island WA 98110
William C. Fanslow - Federal Way WA 98023
Melanie K. Spriggs - Seattle WA 98119
Subhashini Srinivasan - Kirkland WA 98034
Marylou G. Gibson - Carlsbad CA 92009
International Classification:

C12N 512
US Classification:

435377, 435 2, 435326, 435375, 435383
Abstract:

There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor. Also disclosed are methods of simulating hybridoma cells to increase monoclonal antibody production by administering a CD40 ligand polypeptide that stimulates B cell proliferation.

Dna Encoding Cd40 Ligand, A Cytokine That Binds Cd40
view source
US Patent:

6410711, Jun 25, 2002
Filed:

Sep 20, 1999
Appl. No.:

09/399106
Inventors:

Richard J. Armitage - Bainbridge Island WA
William C. Fanslow - Normandy Park WA
Melanie K. Spriggs - Seattle WA
Subhashini Srinivasan - Greenbrae CA
Marylou G. Gibson - Carlsbad CA
Arvia E. Morris - Seattle WA
Jeffrey T. McGrew - Seattle WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

C12N 1519
US Classification:

536 235, 536 231, 536 234, 530350, 530351, 435 691, 435 695, 4352523, 4353201, 435455
Abstract:

There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

Methods Of Treating Autoimmune Disease By Administering Interleukin-17 Receptor
view source
US Patent:

6680057, Jan 20, 2004
Filed:

Apr 14, 2000
Appl. No.:

09/549679
Inventors:

Zhengbin Yao - Lafayette CO
Melanie K. Spriggs - Seattle WA
William C. Fanslow - Federal Way WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 3800
US Classification:

4241921, 514 2, 514885, 424 852, 4241981, 435 697, 435 691, 530350
Abstract:

Isolated receptors for IL-17, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Methods Of Treating Allergy By Administering Interleukin-17 Receptor
view source
US Patent:

7273843, Sep 25, 2007
Filed:

Dec 18, 2003
Appl. No.:

10/742372
Inventors:

Zhengbin Yao - Lafayette CO, US
Melanie K. Spriggs - Seattle WA, US
William C. Fanslow - Federal Way WA, US
Assignee:

Immunex Corporation - Thousand Oaks CA
International Classification:

A61K 38/00
US Classification:

514 2, 530350, 530351
Abstract:

Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Mouse Cd40 Ligand-Specific Antibodies And Hybridomas
view source
US Patent:

7309489, Dec 18, 2007
Filed:

May 28, 1999
Appl. No.:

09/322021
Inventors:

Richard J. Armitage - Bainbridge Island WA, US
William C. Fanslow - Federal Way WA, US
Melanie K. Spriggs - Seattle WA, US
Assignee:

IMMUNEX Corporation - Thousand Oaks CA
International Classification:

A61K 39/395
US Classification:

4241541, 4241301, 4241411, 4241431, 4241441, 4241531, 4241731, 435326, 435332, 435334, 435343, 4353432, 5303871, 5303879, 5303881, 53038822, 5303887, 53038873, 53038875
Abstract:

There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

Methods Of Treating Asthma By Administering Interleukin-17 Receptor
view source
US Patent:

7432237, Oct 7, 2008
Filed:

Dec 18, 2003
Appl. No.:

10/742161
Inventors:

Zhengbin Yao - Lafayette CO, US
Melanie K. Spriggs - Seattle WA, US
William C. Fanslow - Federal Way WA, US
Assignee:

Immunex Corporation - Thousand Oaks CA
International Classification:

A61K 38/00
US Classification:

514 2, 530350, 530351, 435 697
Abstract:

Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Tek Antagonists
view source
US Patent:

20020039992, Apr 4, 2002
Filed:

Dec 7, 2000
Appl. No.:

09/733764
Inventors:

Douglas Cerretti - Seattle WA, US
Luis Borges - Seattle WA, US
William Fanslow - Normandy Park WA, US
International Classification:

A61K039/395
C07H021/04
C12N009/99
A61K038/55
US Classification:

514/002000, 424/130100, 435/184000, 536/023200
Abstract:

The present invention provides Tek antagonists and methods of inhibiting angiogenesis in a mammal by administering Tek antagonists. The methods are particularly useful in treating diseases or conditions mediated by angiogenesis, such as solid tumors and diseases or conditions characterized by ocular neovascularization.

Method For Treatment Of Tumors Using Photodynamic Therapy
view source
US Patent:

20020041864, Apr 11, 2002
Filed:

Apr 25, 2001
Appl. No.:

09/842745
Inventors:

William Fanslow - Normandy Park WA, US
Elaine Thomas - Seattle WA, US
Assignee:

IMMUNEX CORPORATION - Seattle WA
International Classification:

A61K039/395
A61N001/30
A61K038/19
US Classification:

424/085100, 424/155100, 604/020000
Abstract:

A method for treating tumor-bearing subjects that includes administering to the tumor bearing subject a therapeutically effective amount of a CD40 binding protein in conjunction with photodynamic therapy, is disclosed.

William C Fanslow